These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30637125)

  • 1. Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous recombinant tissue plasminogen activator: a systematic review and meta-analysis.
    Guo Y; Yang Y; Zhou M; He L
    Stroke Vasc Neurol; 2018 Dec; 3(4):203-208. PubMed ID: 30637125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis.
    You S; Saxena A; Wang X; Tan W; Han Q; Cao Y; Liu CF
    Stroke Vasc Neurol; 2018 Mar; 3(1):22-27. PubMed ID: 29600004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis.
    Dong Y; Han Y; Shen H; Wang Y; Ma F; Li H; Wang Y; Dong Q
    Stroke Vasc Neurol; 2020 Dec; 5(4):348-352. PubMed ID: 32611728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review.
    Wang X; You S; Sato S; Yang J; Carcel C; Zheng D; Yoshimura S; Anderson CS; Sandset EC; Robinson T; Chalmers J; Sharma VK
    Stroke Vasc Neurol; 2018 Mar; 3(1):28-33. PubMed ID: 29600005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Risk of Hemorrhagic Transformation After Thrombolysis for Acute Ischemic Stroke in Chinese Versus North Americans: A Comparative Study.
    Xu X; Wang D; Wang F; Norton C; Liu X; Selim M
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2381-2387. PubMed ID: 29778315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive model for the risk of hemorrhagic transformation after rt-PA intravenous thrombolysis in patients with acute ischemic stroke: A systematic review and meta-analysis.
    Zhong K; An X; Kong Y; Chen Z
    Clin Neurol Neurosurg; 2024 Apr; 239():108225. PubMed ID: 38479035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
    Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese herbal injections combined with rt-PA intravenous thrombolysis for acute ischemic stroke: A systematic review and meta-analysis protocol.
    Wu J; Wang L; Dong X; Li Z; Wang K; Li L; Liu J
    Medicine (Baltimore); 2021 Mar; 100(10):e25004. PubMed ID: 33725879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.
    Stan A; Dragos H; Strilciuc S; Ilut S; Vacaras V; Cozma A; Panaitescu PS; Stan H; Muresanu DF
    CNS Neurol Disord Drug Targets; 2023; 22(10):1493-1506. PubMed ID: 36200200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Resistance is Significantly Related with Worse Clinical Outcomes in Non-Diabetic Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.
    Yang X; Li C; Li J; Hou D; Luo Y; Zhang S; Jin Z; Shen L; Zhong P; Wu D
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105526. PubMed ID: 33338704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia and In-hospital outcomes in patients with acute ischemic stroke undergoing intravenous thrombolysis: Findings from a nationwide registry study in China.
    Xu Y; Liu C; Zhou Q; Gu H; Jia Y; Meng D; Wang J; Li W; Liu J; Li Z; Yang X; Guo L
    J Stroke Cerebrovasc Dis; 2024 Aug; 33(8):107805. PubMed ID: 38839025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke Thrombolysis in Patients Taking Ticagrelor -Two Successful Cases and a Review of the Literature.
    Landzberg DR; English S; Frankel M; Navalkele D
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105520. PubMed ID: 33310594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-Year Evaluation of the TOYOTA Prehospital Stroke Scale for Tissue Plasminogen Activator Intravenous Therapy in the Real World.
    Suzuki J; Nakai N; Kondo N; Tsuji H; Inagaki R; Furukawa S; Iwata M; Nishida S; Ito Y
    Cerebrovasc Dis; 2018; 46(3-4):184-192. PubMed ID: 30384371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Different Dosages of Alteplase in Atrial Fibrillation-Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan.
    Lin SF; Chen CF; Hu HH; Ho BL; Chen CH; Chan L; Lin HJ; Sun Y; Lin YY; Chen PL; Lin SK; Wei CY; Lin YT; Lee JT; Chao AC;
    J Am Heart Assoc; 2022 Feb; 11(3):e023032. PubMed ID: 35048714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment Blood Pressure is a Simple Predictor of Hemorrhagic Infarction after Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) Therapy.
    Ohtani R; Nakamura M; Nirengi S; Kawakami O; Togawa J; Doi K; Sainouchi M; Kuwata Y; Takata M; Masuda Y; Matsunari R; Takeda K; Tsukahara T; Sakane N
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1979-1986. PubMed ID: 30982718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?
    Dong Y; Cao W; Cheng X; Fang K; Wu F; Yang L; Xie Y; Dong Q
    Stroke Vasc Neurol; 2016 Sep; 1(3):115-121. PubMed ID: 28959472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram to Predict Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke in Asian Population.
    Xie X; Yang J; Ren L; Hu S; Lian W; Xiao J; Pan L; Deng L; Ma J
    Curr Neurovasc Res; 2021; 18(5):543-551. PubMed ID: 34951382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial.
    Song L; Wang X; Robinson T; Lindley RI; Arima H; Lavados PM; Chen X; Chalmers J; Anderson CS
    Stroke Vasc Neurol; 2017 Jun; 2(2):53-58. PubMed ID: 28959492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.
    Bravo Y; Martí-Fàbregas J; Cocho D; Rodríguez-Yáñez M; Castellanos M; de la Ossa NP; Roquer J; Obach V; Maestre J; Martí-Vilalta JL
    Cerebrovasc Dis; 2008; 26(2):126-33. PubMed ID: 18560215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual antiplatelet therapy versus intravenous tissue plasminogen activator with acute minor ischemic stroke: A systematic review and meta-analysis of safety and efficacy.
    Abbas A; Hamad AA; El Din Moawad MH; Ewis DK; Youssef RA; Hamouda H; Hassan MA; Aladawi M; Elfil M; Meshref M; Al-Mufti F
    J Stroke Cerebrovasc Dis; 2024 Jul; 33(7):107704. PubMed ID: 38561167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.